Breaking News Headlines Today | Ground News

See every side of every news story

Pharmaceutical Commerce image

News from Pharmaceutical Commerce

Pharmaceutical Commerce’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Is Pharmaceutical Commerce credible or reliable? Our Factuality score answers both of those questions. When it comes to Pharmaceutical Commerce, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about Pharmaceutical Commerce

Where is Pharmaceutical Commerce located?Pharmaceutical Commerce's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Pharmaceutical Commerce News

Trump Announces Cost Cuts to Weight Loss Drugs — REUTERS / pwu404

GLP-1 · United States

Trump Announces Cost Cuts to Weight Loss Drugs

58% Center coverage: 316 sources

U.S. President Donald Trump announced agreements with pharmaceutical companies Novo Nordisk and Eli Lilly to reduce prices for their obesity drugs Wegovy and Zepbound, respectively, including $50 monthly copays for Medicare patients starting mid-2026 and expanded coverage for those with severe obesity.See the Story

No clear link between acetaminophen use during pregnancy, autism: Review — REUTERS / pwu404

Science · United States

No clear link between acetaminophen use during pregnancy, autism: Review

50% Center coverage: 32 sources

Researchers say evidence linking Tylenol to autism is "critically low."See the Story

Novo Nordisk partners Emcure Pharma for weight loss medicine Poviztra in India

Innovation · India

Novo Nordisk partners Emcure Pharma for weight loss medicine Poviztra in India

New Delhi: Novo Nordisk India and Emcure Pharma on Monday announced a partnership to launch the weight-loss medicine Poviztra, semaglutide injection 2.4 mg, as a second brand of Wegovy in India. Wegovy (semaglutide injection 2.4 mg) was launched in India in June 2025. It is indicated for chronic weight management and reduction in the risk of major adverse cardiovascular events in individuals with overweight or obesity, as an adjunct to a reduced…See the Story

Breaking News Topics Related to Pharmaceutical Commerce